AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2007
Dec 20, 2007
34519_dirs_2007-12-20_4831d7f5-292d-4f45-8f8a-041f3c7b8210.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-12-18
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-12-18 | Common Stock, par value $0.10 per share | P | 405 | $3.53 | Acquired | 412228 | Direct |
| 2007-12-18 | Common Stock, par value $0.10 per share | P | 400 | $3.38 | Acquired | 412628 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 100 | $3.3 | Acquired | 412728 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 200 | $3.66 | Acquired | 412928 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 250 | $3.65 | Acquired | 413178 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 300 | $3.32 | Acquired | 413478 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 400 | $3.28 | Acquired | 413878 | Direct |
| 2007-12-19 | Common Stock, par value $0.10 per share | P | 300 | $3.29 | Acquired | 414178 | Direct |
| 2007-12-20 | Common Stock, par value $0.10 per share | P | 400 | $3.39 | Acquired | 414578 | Direct |
| 2007-12-20 | Common Stock, par value $0.10 per share | P | 200 | $3.44 | Acquired | 414778 | Direct |
| 2007-12-20 | Common Stock, par value $0.10 per share | P | 300 | $3.41 | Acquired | 415078 | Direct |
| 2007-12-20 | Common Stock, par value $0.10 per share | P | 100 | $3.42 | Acquired | 415178 | Direct |
Footnotes
F1: This figure includes 201,710 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23